Conférences - Pharmacologie et développement des médicaments - Allemagne

Sélecionner un pays
1
EMBL Conference: Expanding the Druggable Proteome with Chemical Biology
05 fév 2020 - 07 fév 2020 • Heidelberg, Allemagne
Résumé:
Chemical biology is a scientific discipline that promises to apply the latest chemical approaches to interrogate complex biological systems and is, consequently, at the very heart of modern pharmacology. This conference will explore how recent advances in chemical biology are helping to expand the druggable proteome and enhance our understanding of disease biology .
Contact:
EMBL Events;     Tél.: [+49 6221 387 8797];     Email.: events@embl.de
Sujets:
Drug discovery, chemical biology, genomics, DNA-sensing pathways, proteolysis targeting chimeras (PROTACs), targeted protein degradation, druggable proteome, druggable genome, phenotypic screens, chemical probes, chemogenomics, bioinformatics
Identifiant de l'évènement:
1242764
2
ITOC7 — 7th Immunotherapy of Cancer Conference
02 avr 2020 - 04 avr 2020 • Munich, Allemagne
Organisateur:
ITOC7 is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Society for Immunotherapy of Cancer (SITC), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munic
Résumé:
The 7th Immunotherapy of Cancer Conference (ITOC7) to be held in Munich, Germany from April 2 – 4, 2020 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges. The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.
Contact:
WMA GmbH Congress Office;     Tél.: [+431405138318];     Email.: itoc@medacad.org
Sujets:
Emerging concepts / novel agents Microbiome and immune system/immunotherapy Tumor microenvironment Vaccine Therapy Precision Medicine Meets Immunotherapy (Immuno-Monitoring) Cell Therapy in Solid Tumors Cell Therapy in Haematologic Diseases Combination Therapy
Identifiant de l'évènement:
1300552
Sujets apparentés:
3
ECI — Pharmaceutical Engineering: At the Frontier of Drug Substance and Drug Product
03 mai 2020 - 07 mai 2020 • Irsee, Allemagne
Organisateur:
Engineering Conferences International (ECI)
Résumé:
It is well known that the physical and chemical properties of the DS (API) have major impacts on the formulation and the Drug Product (DP) process. In any dosage form including solid, liquid and semi-solid, the Drug Substance (DS) or Active Pharmaceutical Ingredient (API) goes through a formulation process. This process to make the final drug product serves many purposes, but all with the goal of eventually delivering the active ingredient to the desired sites in the patients’ body in the most convenient way and to achieve optimal therapeutic effect.
Contact:
Tél.: [2125146760];     Email.: noel@engconfintl.org
Sujets:
Role particle engineering process scaleup Pharmaceutical composite materials DS/DP interface integration DS (API)
Identifiant de l'évènement:
1217720
4
DDSEU 2020 — 21st Annual Drug Discovery and 8th Annual Drug Design & Medicinal Chemistry Congress
26 mai 2020 - 27 mai 2020 • Berlin, Allemagne
Organisateur:
Oxford Global
Résumé:
The events are aimed at VPs and senior directors of discovery in biology and chemistry from global pharmaceutical and biotech organisations. New for 2020, the event features focused R&D leaders sessions on Drug discovery Modalities and AI in drug development. It will also highlights successful strategies in delivering On Target Discovery, Phenotypic/Crispr Screening, Applications Of Organ-In-A Chip Platforms As Well As Tissue And 3D Culture For Disease Modelling. Empowering Drug Discovery with Chemical Biology, senior experts will also learn about enabling technologies that facilitate quicker drug development timelines such as protein degradation tools, target-based discovery techniques including RNA as novel targets. Do not miss out on cutting edge insights into computational chemistry and drug design methods.
Contact:
Tél.: [+441865248455];     Email.: g.alonso@oxfordglobal.co.uk
Sujets:
Drug Discovery, Drug Design, Medicinal Chemistry
Identifiant de l'évènement:
1301520


Conference-Service.com met à la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs. Noter que, malgré tout le soin que nous apportons à la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc à vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager à y participer!

Dernière mise à jour: 27 Novembre 2019